Skip to content

Efficacy of Kusthahar kashay ghan and Manjisthadi tail in fungal infection.

Randomized controlled clinical trial to evaluate the efficacy of kusthahar kashay ghan and Manjisthadi tail in Dadru kustha with special referance to Fungal Dermatophytosis. - NIL

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067731
Enrollment
130
Registered
2024-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Dr Sameer Pralhad Shinde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having clinical signs and symptoms of Dadru kustha like Udgat mandal(Raised skin patch), Kandu(Itching),Raga (redness),Pidaka(eruption), Daha(Burning).

Exclusion criteria

Exclusion criteria: preganant and lactating Mothers Patients having chrnicity of Dadru Kustha more than 5 yrs Patients having serious illness like HIV, Maliganancy,Cardiac Disease, Major Liver Diseases,End Stage Renal Disease. Patients having other associated skin diseases liks Eczema, SLE and Secondary Bacterial infections.

Design outcomes

Primary

MeasureTime frame
To Study the antifungal activity of Kushthahar kashay Ghan and Manjishthadi Tail in Dadru Kushtha.Timepoint: 4 weeks

Secondary

MeasureTime frame
Adverse reactions if any After administration of Kusthahar kashay ghan and Manjisthadi TailTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Sameer Shinde

Yashwant Ayurvedic college post graduate Training and Research centre, Kodoli, Kolhapur

suryakiran_wagh@rediffmail.com9822846910

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026